Cargando…
Curcumin reduces expression of Bcl-2, leading to apoptosis in daunorubicin-insensitive CD34(+ )acute myeloid leukemia cell lines and primary sorted CD34(+ )acute myeloid leukemia cells
BACKGROUND: Acute myeloid leukemia (AML) is an immunophenotypically heterogenous malignant disease, in which CD34 positivity is associated with poor prognosis. CD34(+ )AML cells are 10-15-fold more resistant to daunorubicin (DNR) than CD34(- )AML cells. Curcumin is a major component of turmeric that...
Autores principales: | Rao, Jia, Xu, Duo-Rong, Zheng, Fei-Meng, Long, Zi-Jie, Huang, Sheng-Shan, Wu, Xing, Zhou, Wei-Hua, Huang, Ren-Wei, Liu, Quentin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3118333/ https://www.ncbi.nlm.nih.gov/pubmed/21595920 http://dx.doi.org/10.1186/1479-5876-9-71 |
Ejemplares similares
-
Isolation and Characterization of CD34+ Blast-Derived Exosomes in Acute Myeloid Leukemia
por: Hong, Chang Sook, et al.
Publicado: (2014) -
Differentially expressed genes responsible for insensitivity of CD34+ cells to kinase inhibitors in patients with chronic myeloid leukemia
por: Moreira-Nunes, Caroline FA, et al.
Publicado: (2013) -
High frequency of CD34+CD38-/low immature leukemia cells is correlated with unfavorable prognosis in acute myeloid leukemia
por: Plesa, Adriana, et al.
Publicado: (2017) -
Integration of CD34(+)CD117(dim) population signature improves the prognosis prediction of acute myeloid leukemia
por: Li, Xue-Ping, et al.
Publicado: (2022) -
Anti-CD123 antibody-modified niosomes for targeted delivery of daunorubicin against acute myeloid leukemia
por: Liu, Fu-rong, et al.
Publicado: (2017)